Hoverink biotechnologies inc
Web23 de jan. de 2024 · Los Angeles, Jan. 23, 2024 -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by Cyrus Sajna as CEO and CFO of the company. ... WebFor Body Armor Sales, Media and Investor Contact: Cyrus Sajna, Vice President Direct 310-467-2048 or 866-443-4666 EXT 113 Hoverink Biotechnologies, Inc. Los Angeles, California 90067 Oct 8, 2024 Hoverink Biotechnologies Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082024 Prices from USD $250
Hoverink biotechnologies inc
Did you know?
Web27 de set. de 2024 · CENTURY CITY, CA / ACCESSWIRE / September 26, 2024 / Hoverink Biotechnologies, Inc., today announced that they have plans to develop and … Web5 de jul. de 2024 · LOS ANGELES, CA, July 05, 2024 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for injection) and an oral formulation of LADAVRU®. HOVERINK BIOTECHNOLOGIES seeks to partner and receive an up-front …
WebHoverink Biotechnologies Inc. Hoverink Biotechnologies, Inc. operates as a preclinical biopharmaceutical company. The Company develops and manufactures drug for age … Web26 de set. de 2024 · Trademark Overview. On Wednesday, September 26, 2024, a trademark application was filed for KAIYADRU with the United States Patent and Trademark Office. The USPTO has given the KAIYADRU trademark a serial number of 88133141. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE …
WebDebbie Mae Carter is Former CEO/Treasurer at Hoverink Biotechnologies Inc. See Debbie Mae Carter's compensation, career history, education, & memberships. WebHoverink Biotechnologies, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hoverink Biotechnologies, Inc..
Web27 de mar. de 2024 · Hoverink Biotechnologies doesn't have any recent trademark applications, indicating Hoverink Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans. Trademark ...
WebCyrus Sajna is Interim CEO/CFO at Hoverink Biotechnologies Inc. See Cyrus Sajna's compensation, career history, education, & memberships. greer sc christmas tree lightingWeb12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. November 12, 2024 14:30 ET Source: … fob wildernessWebHoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 [email protected] ... greer sc chamber of commerceWebWHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Cyrus Sajna , (the “Vice President”) in recognition and appreciation of services previously performed by the Vice President on behalf of the Company is an effective … greer sc car dealershipsWebWHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s … fob wilson lyricsWeb23 de jan. de 2024 · Hoverink Biotechnologies, Inc., today announced Hoverink CEO Debbie Carter Steps Down; Cyrus Sajna Appointed as her Successor January 23, 2024, … greer sc business license applicationWeb23 de jan. de 2024 · Hoverink Biotechnologies, Inc., today announced Hoverink CEO Debbie Carter Steps Down; Cyrus Sajna Appointed as her Successor [January 23, 2024] Los Angeles, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by … fob wilderness paktya